Delta 9 Cannabis 2Q Rev C$18.3M; Loss/Shr C$0.02
ECN Capital Announces Partnership, Strategic Investment by Skyline Champion; 2Q Adj EPS $0.00
Greenbrook TMS 2Q Rev $18.3M Vs. $14.2M; 6-Mos Rev $38.3M Vs. $27.3M; Rev Growth Mainly Due to Acquisition of Success TMS in 2022; Significantly Reduced Marketing Spend Also Helped Results; On Track for Target of $22M-$25M in Cost Reductions Once Restructuring Completes; 6-Mos Loss/Shr $0.60 Vs. Loss $0.85; 2Q Loss/Shr $0.30 Vs. Loss $0.41; Has Boosted Liquidity via Financing Transactions, Secured Further Capital to Finish Restructuring, Achieve Profitability
Intermap 2Q Rev $1.6M
Lithium Royalty 2Q Loss/Shr 2c
Lucara Diamond to Name William Lamb as President, CEO, to Board; Lamb to Succeed Eira Thomas
Mattr to Sell Part of Pipeline, Pipe Services Segment to Tenaris for About C$220 Million
ProMIS Neurosciences 2Q Loss/Shr 27c
Skyline Champion to Invest C$185M in ECN Capital
Suncor Energy 2Q EPS C$1.43; Rev C$12.43B
Titanium Transportation 2Q Rev C$100.4M; EPS C$0.07; Sees 2023 Rev C$450M-C$470M
VIQ Solutions 2Q Loss/Shr 10c; Rev $10.5M
Expected Major Events for Tuesday
04:30/JPN: Jun Revised Retail Sales
04:30/JPN: Jun Revised Industrial Production
06:00/UK: Jul UK monthly unemployment figures
09:00/GER: Aug ZEW Indicator of Economic Sentiment
12:30/US: Jul Import & Export Price Indexes
12:30/CAN: Jun Monthly Survey of Manufacturing
12:30/CAN: Jun New motor vehicle sales
12:30/US: Aug Empire State Manufacturing Survey
12:30/CAN: Jul CPI
12:30/US: Jul Advance Monthly Sales for Retail & Food Services
12:55/US: 08/12 Johnson Redbook Retail Sales Index
14:00/US: Aug NAHB Housing Market Index
14:00/US: Jun Manufacturing & Trade: Inventories & Sales
20:00/US: Jun Treasury International Capital Data
20:30/US: 08/11 API Weekly Statistical Bulletin
23:01/UK: Jul Scottish Retail Sales Monitor
All times in GMT. Powered by Kantar Media and Dow Jones.
Expected Earnings for Tuesday
AEterna Zentaris Inc (AEZS,AEZS.T) is expected to report for 2Q.
AIM ImmunoTech Inc (AIM) is expected to report for 2Q.
AVROBIO Inc (AVRO) is expected to report $-0.53 for 2Q.
Accord Financial (ACD.T) is expected to report for 2Q.
Bio-Path Holdings Inc (BPTH) is expected to report for 2Q.
Cardinal Health Inc (CAH) is expected to report $1.22 for 4Q.
DecisionPoint Systems Inc (DPSI) is expected to report for 2Q.
Drive Shack Inc (DSHK) is expected to report $-0.06 for 2Q.
Empire Petroleum Corp (EP) is expected to report for 2Q.
Enliven Therapeutics Inc (ELVN) is expected to report for 2Q.
FTI Consulting (FCN) is expected to report $1.79 for 4Q.
First Guaranty Bancshares (FGBI) is expected to report $0.25 for 2Q.
Gossamer Bio Inc (GOSS) is expected to report $-0.46 for 2Q.
Greenhill & Co Inc (GHL) is expected to report $-0.14 for 2Q.
Gyrodyne LLC (GYRO) is expected to report for 2Q.
Hennessy Advisors Inc (HNNA) is expected to report for 3Q.
Home Depot Inc (HD) is expected to report $4.48 for 2Q.
Infinity Pharmaceuticals (INFI) is expected to report $0.03 for 2Q.
Ispire Technology Inc (ISPR) is expected to report for 4Q.
Ituran Location & Control Ltd (ITRN,ITRN-TV) is expected to report for 2Q.
Legend Biotech Corp ADR (LEGN) is expected to report for 2Q.
Lyra Therapeutics Inc (LYRA) is expected to report for 2Q.
Mercury Systems Inc (MRCY) is expected to report $0.10 for 4Q.
Milestone Scientific Inc (MLSS) is expected to report $-0.02 for 2Q.
Mondee Holdings Inc (MOND) is expected to report for 2Q.
POINT Biopharma Global Inc (PNT) is expected to report for 2Q.
Perpetua Resources Corp (PPTA.T) is expected to report for 2Q.
Quipt Home Medical Corp (QIPT.T) is expected to report for 3Q.
RM2 International Inc (RMTO) is expected to report for 3Q.
Rare Element Resources Ltd (REEMF,RES-T) is expected to report for 2Q.
Rubius Therapeutics Inc (RUBY) is expected to report $-0.50 for 1Q.
Rubius Therapeutics Inc (RUBY) is expected to report $-0.53 for 2Q.
Solitario Resources Corp (SLR.T,XPL) is expected to report for 2Q.
Syneos Health Inc (SYNH) is expected to report $0.06 for 2Q.
Sypris Solutions (SYPR) is expected to report for 2Q.
Terran Orbital Corp (LLAP) is expected to report for 2Q.
ViewRay Inc (VRAYQ) is expected to report $-0.15 for 2Q.
Viracta Therapeutics Inc (VIRX) is expected to report for 2Q.
Westwater Resources Inc (WWR) is expected to report for 2Q.
Wilmington Capital Management Inc - Class A (WCM.A.T,WCM.B.T) is expected to report for 2Q.
Powered by Kantar Media and Dow Jones.
ANALYST RATINGS ACTIONS
Anika Therapeutics Raised to Outperform From Market Perform by Barrington Research
Atreca Cut to Neutral From Outperform by Wedbush
Berry (bry) Cut to Neutral From Overweight by Piper Sandler
Boston Properties Cut to Hold From Buy by Argus Research
Braemar Hotels & Resorts Cut to Neutral From Buy by B. Riley Securities
CF Industries Cut to Equal-Weight From Overweight by Barclays
Coterra Energy Raised to Overweight From Neutral by Piper Sandler
EPR Properties Cut to Neutral From Buy by B of A Securities
Keysight Technologies Cut to Underperform From Neutral by B of A Securities
Marriott Cut to Market Perform From Outperform by Bernstein
Mosaic Cut to Underweight From Equal-Weight by Barclays
Northern Oil Cut to Neutral From Overweight by Piper Sandler
Okta Raised to Buy From Sell by Goldman Sachs
OpGen Cut to Neutral From Buy by HC Wainwright & Co.
Parsons Raised to Buy From Underperform by B of A Securities
Public Service Enterprise Cut to Neutral From Buy by UBS
Range Resources Cut to Hold From Buy by Seibert Williams
Stellus Capital Invest Cut to Perform From Outperform by Oppenheimer
Teledyne Raised to Buy From Neutral by Goldman Sachs
Urban Outfitters Cut to Neutral From Buy by Citigroup
W. P. Carey Cut to Underperform From Neutral by B of A Securities
Xos Cut to Neutral From Buy by DA Davidson
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
08-15-23 0616ET
